Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota

COMMENTED

Gastrointestinal CancerInflammatory Bowel Disease

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Gut Microbes

Morsy Y, Walberg Å, Wawrzyniak P, Hubeli B, Truscello L, Mamie C, Niechcial A, Gueguen E, Manzini R, Gottier C, Lang S, Scharl S, Blümel S, Biedermann L, Rogler G, Turina M, Ramser M, Petrowsky H, Arnold IC, Zeissig S, Zamboni N, Egli A, Niess JH, Hruz P, Knuth A, Fritsch R, Manz MG, Wawrzyniak M, Scharl M

doi: 10.1080/19490976.2025.2530157

Inflammatory Bowel Disease

Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers

J Crohns Colitis

Baldán-Martín M, Iloro I, Azkargorta M, Soleto I, Orejudo M, Ramirez C, Mercado J, Suárez-Trujillo F, Sánchez-Sánchez C, Garre A, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, Fernández-Salazar L, Ceballos D, Benítez JM, Aguas M, Bastón-Rey I, Bermejo F, Casanova MJ, Lorente-Poyatos RH, Ber Y, Ginard D, Esteve M, De Francisco R, García MJ, Francés R, Cabriada JL, Soto P, Nos P, Acosta MB, Guerra I, Cruz DH, Domínguez Cajal M, Royo V, Aceituno M, Martín-Cófreces NB, Elortza F, Gisbert JP, Chaparro M

doi: 10.1093/ecco-jcc/jjaf177

COMMENTED

Esophagus Diseases

Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

BMC Gastroenterol

Theswet E, Brücker C, Kreienbühl A, Greuter T, Schoepfer AM, Straumann A, Biedermann L

doi: 10.1186/s12876-025-03942-8

Inflammatory Bowel Disease

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

J Crohns Colitis

D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S

doi: 10.1093/ecco-jcc/jjaf080

Inflammatory Bowel Disease

Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies

Inflamm Bowel Dis

Füchtbauer JD, Brovkina O, Sivickis K, Aalykke C, Høivik ML, Andersen V, Halfvarson J, Bang C, Franke A, Kjeldsen J

doi: 10.1093/ibd/izaf217

Inflammatory Bowel Disease

Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease

Inflamm Bowel Dis

Meima M, Westerhout J, Meijerink M, Bijlsma S, van Schaik F, Oldenburg B, Houben G

doi: 10.1093/ibd/izaf126

RECOMMENDED

Inflammatory Bowel Disease

Radiation exposure in patients with inflammatory bowel disease

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

J Crohns Colitis

Jorissen T, Fierens L, Bosmans H, Verstockt B, Sabino J, Vermeire S, Vanbeckevoort D, Ferrante M

doi: 10.1093/ecco-jcc/jjaf001

Inflammatory Bowel Disease

Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City

Inflamm Bowel Dis

Klein S, Sivasailam B, Alizadeh M, Malter L, Axelrad JE

doi: 10.1093/ibd/izaf174

Inflammatory Bowel Disease

Non-colorectal Cancer Screening and Vaccinations in Patients with Inflammatory Bowel Disease: Expert Review

Clin Gastroenterol Hepatol

Caldera F, Kane S, Long M, Hashash JG

doi: 10.1016/j.cgh.2024.12.011

Related content

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease

Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers

Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies

Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease

Radiation exposure in patients with inflammatory bowel disease

Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City

Non-colorectal Cancer Screening and Vaccinations in Patients with Inflammatory Bowel Disease: Expert Review